Andrés Cruz-Herranz, M.D., Ph.D.

Director, Clinical Development at Prilenia
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Greater Barcelona Metropolitan Area, ES
Languages
  • English Full professional proficiency
  • French Professional working proficiency
  • Italian Full professional proficiency
  • Spanish Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • Prilenia
    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Director, Clinical Development
      • Jul 2022 - Present

      • Huntington, ALS (Phase 2 & 3) • Huntington, ALS (Phase 2 & 3)

  • Denali Therapeutics
    • United States
    • Biotechnology Research
    • 200 - 300 Employee
    • Associate Medical Director, Early Clinical Development
      • 2019 - 2022

      · Clinical Lead, LRRK2 (Parkinson's) and TREM2 (Alzheimer's) Programs · Medical Monitor, RIPK1 Program (Alzheimer's & ALS) · ETV:IDS Program (MPS II, Hunter syndrome) · Clinical Lead, LRRK2 (Parkinson's) and TREM2 (Alzheimer's) Programs · Medical Monitor, RIPK1 Program (Alzheimer's & ALS) · ETV:IDS Program (MPS II, Hunter syndrome)

  • Genentech
    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Clinical Research Fellow, Development Neuroscience
      • 2018 - 2019

      · Programs: Ocrelizumab in Multiple Sclerosis (Phases 3 & 4); Crenezumab in Alzheimer's (Phase 3) · Programs: Ocrelizumab in Multiple Sclerosis (Phases 3 & 4); Crenezumab in Alzheimer's (Phase 3)

  • Frontiers
    • Switzerland
    • Research Services
    • 700 & Above Employee
    • Review Editor for Neuro-ophthalmology
      • 2017 - 2018

  • University of California, San Francisco
    • United States
    • Higher Education
    • 700 & Above Employee
    • Postdoctoral Research Fellow, Multiple Sclerosis Center -Dr. Ari Green Lab
      • 2013 - 2018

      · Project: “Longitudinal Screening of Neuroprotective Therapies in Experimental Autoimmune Encephalomyelitis with Optical Coherence Tomography” · Project: “Cellular and transcriptomic dynamics of retinal innate immunity in neuroinflammatory disease: a new therapeutic approach for progressive MS and other neurodegenerative diseases” · Project: “Longitudinal Screening of Neuroprotective Therapies in Experimental Autoimmune Encephalomyelitis with Optical Coherence Tomography” · Project: “Cellular and transcriptomic dynamics of retinal innate immunity in neuroinflammatory disease: a new therapeutic approach for progressive MS and other neurodegenerative diseases”

  • AMIR
    • Spain
    • Higher Education
    • 100 - 200 Employee
    • Professor of Neurology and Neurosurgery
      • 2009 - 2018

      Postgraduate Specialization Boards

    • Student Tutor
      • 2009 - 2011

      Postgraduate Specialization Boards

  • Hospital Los Madroños
    • Neurologist
      • Jul 2013 - Dec 2013

  • Clínica San Vicente
    • On-call Neurologist
      • Sep 2013 - Oct 2013

  • Instituto Fundación San José
    • Neurologist
      • Jul 2013 - Oct 2013

  • UCSF Health
    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Observing Medical Resident
      • 2013 - 2013

  • Hospital Universitario La Paz
    • Madrid, Community of Madrid, Spain
    • Neurology Resident
      • 2009 - 2013

  • Ospedale San Raffaele
    • Italy
    • Hospitals and Health Care
    • 700 & Above Employee
    • Observing Medical Resident. Centro di Sclerosi Multipla
      • 2012 - 2012

  • Universidad Autónoma de Madrid
    • Spain
    • Higher Education
    • 700 & Above Employee
    • International Relations Officer
      • 2007 - 2008

Education

  • University of California, San Francisco
    Course, Pharmacokinetics for Pharmaceutical Scientists Course
    2020 - 2020
  • Universidad Autónoma de Madrid
    Doctor of Medicine (MD)
  • University of Barcelona
    Doctor of Philosophy - PhD, Translational Neuroscience
  • La Paz University Hospital
    Residency in Neurology
    2009 - 2013
  • NIH Clinical Center
    Course, Introduction to the Principles and Practice of Clinical Research
    2016 - 2017
  • University of California, Berkeley
    Course, US Food and Drug Administration, Drug Development, Science and Health Policy
    2017 - 2017
  • Università degli Studi di Milano
    M, Socrates-Erasmus Grant
    2006 - 2007
  • Universidad Pablo de Olavide
    Masters in Neuroscience, Medicine
    2009 - 2010
  • Universidad Pablo de Olavide
    Máster en Sueño: Medicina y Fisiología, Medicina
    2010 - 2011

Community

You need to have a working account to view this content. Click here to join now